Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2013
09/04/2013EP2633756A1 Pest control composition including novel iminopyridine derivate
09/04/2013EP2632914A1 New sterically hindered polymeric amines and their use as polymer stabilizers
09/04/2013EP2632913A1 Novel microbicides
09/04/2013EP2632903A2 Metalloenzyme inhibitor compounds
09/04/2013EP2632551A1 Soluble guanylate cyclase activators
09/04/2013EP2632268A2 Novel compounds that are erk inhibitors
09/04/2013EP2632255A1 Diazeniumdiolate heterocyclic derivatives
09/04/2013EP2632253A1 Process for the preparation of an orexin receptor antagonist
09/04/2013CN103282360A Cxcr4受体拮抗剂 Cxcr4 receptor antagonist
09/04/2013CN103282359A Crystalline forms of 5-chloro-N2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-N4[2-(propane-2-sulfonyl)-phenyl]-pyrimidine-2,4-diamine
09/04/2013CN103282358A Cyp11b, cyp17, and/or cyp21 inhibitors
09/04/2013CN103282357A Pyrrolidine derivatives as NK3 antagonists
09/04/2013CN103282354A N-(tetrazol-5-l)- and n-(triazol-5-yl)arylcarboxamides and use thereof as herbicides
09/04/2013CN103282352A Benzamides and nicotinamides as syk modulators
09/04/2013CN103282347A Pesticidal arylpyrrolidines
09/04/2013CN103275699A Pyrrole pyridine salt fluorescent probe used for RNA (ribonucleic acid) and nucleolus imaging in living cell
09/04/2013CN103275068A Preparation method of nilotinib
09/04/2013CN103275067A Inhibitors of histone deacetylase
09/04/2013CN103275066A 3, 5-disubstituted 4-aminotriazole compound, as well as preparation method and application thereof
09/04/2013CN103275065A Novel method for producing dabigatran etexilate
09/04/2013CN103275064A Preparation method of Esomeprazole and preparation method of Esomeprazole sodium
09/04/2013CN103275063A Method for preparing halofuginone hydrobromide
09/04/2013CN103275062A Purification method for Pomalidomide
09/04/2013CN103275024A Azole antifungal compound and its preparation method and application
09/04/2013CN103275017A 2-substituted quinazolinone compound, its synthesis method and application
09/04/2013CN103275008A 3,4,5-trisubstituted pyrazole compound and preparation method thereof
09/04/2013CN102702172B Esomeprazole sodium preparation method
09/04/2013CN102603621B Novel chiral sulfoxide compound and method for preparing esomeprazole by using novel chiral sulfoxide compound
09/04/2013CN102470130B Crystalline freebase forms of a biphenyl compound
09/04/2013CN102358735B Low toxicity multiple-point guided drug, nitrogen-containing aromatic ring CB1 receptor inhibitor with hydroxyl or substituted hydroxyl, and pharmaceutical use thereof
09/04/2013CN102267948B Fluoreno diimidazole derivatives and preparation method thereof
09/04/2013CN102229800B Pyrazoline derivative Zn<2+> fluorescence probe and its application
09/04/2013CN102089290B Triazole derivatives useful for the treatment of diseases
09/04/2013CN101824027B Polysubstituted tetrahydroquinoline derivative with optical activity and synthetic method and use thereof
09/04/2013CN101553460B Process for preparing 2-amino-5-cyanobenzoic acid derivatives
09/04/2013CN101374820B Piperazine compounds with a herbicidal action
09/03/2013US8524917 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
09/03/2013US8524909 Tetrahydro-pyran derivatives
09/03/2013US8524900 Fused heterocyclic derivatives and methods of use
09/03/2013US8524894 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1
09/03/2013US8524728 Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
09/03/2013US8524724 Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
09/03/2013US8524722 Substituted tricyclic compounds and methods of use thereof
09/03/2013US8524721 Platelet ADP receptor inhibitors
09/03/2013US8524720 Substituted N-(pyrazol-5-yl)-pyrrolo[3,2-D]pyrimidin-4-amine useful as protein kinase inhibitors
09/03/2013US8524714 7-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
09/03/2013US8524712 Triazinone and diazinone derivatives useful as HSP90 inhibitors
09/03/2013US8524711 Amino-derivatives as novel inhibitors of histone deacetylase
09/03/2013US8524710 Pyrrolidine derivatives
09/03/2013US8524709 Kinase inhibitor compounds
09/03/2013US8524700 Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
09/03/2013US8524699 Substituted dihydropyrazolones and use thereof as HIF-prolyl-4-hydroxylase inhibitors
09/03/2013CA2670633C Anthrapyridone compound or salt thereof, magenta ink composition containing the same, and colored product
09/03/2013CA2667372C 1,5-diphenyl-3-benzylamino-1,5-dihydropyrrolidin-2-one as cb1 receptor modulators
09/03/2013CA2522562C 2-phenyl-benzimidazol and 2-phenyl-imidazo-`4,5!-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer
08/2013
08/29/2013WO2013126664A1 Identification of nsc23925 isomers to reverse multidrug resistance in human cancers
08/29/2013WO2013126608A1 Sulfonamide compounds and uses as tnap inhibitors
08/29/2013WO2013126394A1 Solid forms of 3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
08/29/2013WO2013126326A1 Solid forms of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione, compositions and methods of use thereof
08/29/2013WO2013124749A1 Novel polymorph of dabigatran etexilate
08/29/2013WO2013124385A2 Solid forms of dabigatran etexilate mesylate and processes for their preparation
08/29/2013WO2013124335A1 Antiviral compounds
08/29/2013WO2013124169A1 Use of 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors
08/29/2013WO2013124158A1 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors
08/29/2013US20130225821 Synthesis of thiohydantoins
08/29/2013US20130225819 Use of azides in synthesis
08/29/2013US20130225816 Process for the preparation of substituted pyrimidine derivatives
08/29/2013US20130225638 Imidazole derivatives and preparation method and use thereof
08/29/2013US20130225637 Isatin derivatives, pharmaceutical compositions thereof, and methods of use thereof
08/29/2013US20130225621 Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of stat protein
08/29/2013US20130225619 Substituted heterocyclic compounds for disease treatment
08/29/2013US20130225617 Indoles and their therapeutic use
08/29/2013US20130225606 N-hetarylmethyl pyrazolylcarboxamides
08/29/2013US20130225599 Novel pyrrolidine derived beta 3 adrenergic receptor agonists
08/29/2013US20130225596 Novel heterocyclic derivative and pharmaceutical composition comprising the same (as amended)
08/29/2013US20130225587 Compound for increasing kinase active and application thereof
08/29/2013US20130225583 Substituted amino-triazolyl pde10 inhibitors
08/29/2013US20130225581 Nitrogen-containing aromatic heterocyclic derivative
08/29/2013US20130225580 Aza-aryl 1h-pyrazol-1-yl benzene sulfonamides
08/29/2013US20130225579 Cyanoquinoline derivatives
08/29/2013US20130225575 Methods for treating neurological conditions
08/29/2013US20130225571 Manufacturing process for pyrimidine derivatives
08/29/2013US20130225567 5-Alkynyl Pyridine
08/29/2013US20130225563 Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor
08/29/2013US20130225562 Pyridyltriazoles
08/29/2013US20130225548 Pyridine Derivative and Medicinal Agent
08/29/2013US20130225524 Chemical Compounds
08/29/2013US20130224288 F, G, H, I and K Crystal Forms of Imatinib Mesylate
08/29/2013US20130224195 Substituted benzazoles and methods of their use as inhibitors of raf kinase
08/29/2013US20130224151 Use of FAAH Inhibitors for Treating Abdominal, Visceral and Pelvic Pain
08/29/2013US20130224114 Translocator Protein Ligands
08/29/2013CA2857262A1 Antiviral compounds
08/28/2013EP2631235A2 Pest control agent
08/28/2013EP2631234A1 Solid forms of dabigatran etexilate mesylate and processes for their preparation
08/28/2013EP2631233A1 Antagonist for mutated androgen receptor
08/28/2013EP2631229A1 P2x4 receptor antagonist
08/28/2013EP2630142A1 Novel substituted picolinic acids, salts and acid derivatives thereof, and use thereof as herbicides
08/28/2013EP2630138A2 1-(heterocyclic carbonyl)-2-substituted pyrrolidines and their use as fungicides
08/28/2013EP2630137A1 Sterically hindered amine light stabilizers with mixed functionalization
08/28/2013EP2630136A1 Selective cyp11b1 inhibitors for the treatment of cortisol dependent diseases
1 ... 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 ... 1080